These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35335958)

  • 1. Nanomaterials Aiming to Tackle Antibiotic-Resistant Bacteria.
    Munir MU; Ahmad MM
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combatting antibiotic-resistant bacteria using nanomaterials.
    Gupta A; Mumtaz S; Li CH; Hussain I; Rotello VM
    Chem Soc Rev; 2019 Jan; 48(2):415-427. PubMed ID: 30462112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomaterials: The New Antimicrobial Magic Bullet.
    Ndayishimiye J; Kumeria T; Popat A; Falconer JR; Blaskovich MAT
    ACS Infect Dis; 2022 Apr; 8(4):693-712. PubMed ID: 35343231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on Usage of Functional Nanomaterials in Antimicrobial Therapy for Antibiotic-Resistant Bacterial Infections.
    Karnwal A; Kumar G; Pant G; Hossain K; Ahmad A; Alshammari MB
    ACS Omega; 2023 Apr; 8(15):13492-13508. PubMed ID: 37091369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-bacterial activity of inorganic nanomaterials and their antimicrobial peptide conjugates against resistant and non-resistant pathogens.
    Pardhi DM; Şen Karaman D; Timonen J; Wu W; Zhang Q; Satija S; Mehta M; Charbe N; McCarron PA; Tambuwala MM; Bakshi HA; Negi P; Aljabali AA; Dua K; Chellappan DK; Behera A; Pathak K; Watharkar RB; Rautio J; Rosenholm JM
    Int J Pharm; 2020 Aug; 586():119531. PubMed ID: 32540348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-Resistant Pathogens in Burn Wound, Prevention, Diagnosis, and Therapeutic Approaches (Conventional Antimicrobials and Nanoparticles).
    Hemmati J; Azizi M; Asghari B; Arabestani MR
    Can J Infect Dis Med Microbiol; 2023; 2023():8854311. PubMed ID: 37521436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomaterials-Based Combinatorial Therapy as a Strategy to Combat Antibiotic Resistance.
    León-Buitimea A; Garza-Cárdenas CR; Román-García MF; Ramírez-Díaz CA; Ulloa-Ramírez M; Morones-Ramírez JR
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dealing with MDR bacteria and biofilm in the post-antibiotic era: Application of antimicrobial peptides-based nano-formulation.
    Song X; Liu P; Liu X; Wang Y; Wei H; Zhang J; Yu L; Yan X; He Z
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112318. PubMed ID: 34474869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macromolecular Nanotherapeutics and Antibiotic Adjuvants to Tackle Bacterial and Fungal Infections.
    Dey R; Mukherjee S; Barman S; Haldar J
    Macromol Biosci; 2021 Nov; 21(11):e2100182. PubMed ID: 34351064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biogenic Nanosilver against Multidrug-Resistant Bacteria (MDRB).
    Barros CHN; Fulaz S; Stanisic D; Tasic L
    Antibiotics (Basel); 2018 Aug; 7(3):. PubMed ID: 30072622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterials for Fighting Multidrug-Resistant Biofilm Infections.
    Rotello VM
    BME Front; 2023; 4():0017. PubMed ID: 37849666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging antibacterial nanomedicine for enhanced antibiotic therapy.
    Wang S; Gao Y; Jin Q; Ji J
    Biomater Sci; 2020 Dec; 8(24):6825-6839. PubMed ID: 32996490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
    Mba IE; Nweze EI
    World J Microbiol Biotechnol; 2021 May; 37(6):108. PubMed ID: 34046779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms.
    Hoseinzadeh E; Makhdoumi P; Taha P; Hossini H; Stelling J; Kamal MA; Ashraf GM
    Curr Drug Metab; 2017; 18(2):120-128. PubMed ID: 27908256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2D and Heterostructure Nanomaterial Based Strategies for Combating Drug-Resistant Bacteria.
    Begum S; Pramanik A; Davis D; Patibandla S; Gates K; Gao Y; Ray PC
    ACS Omega; 2020 Feb; 5(7):3116-3130. PubMed ID: 32118128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent strategies for inhibiting multidrug-resistant and β-lactamase producing bacteria: A review.
    Fatima H; Goel N; Sinha R; Khare SK
    Colloids Surf B Biointerfaces; 2021 Sep; 205():111901. PubMed ID: 34116398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Nanoparticles in the Inhibition of Multidrug-Resistant Bacteria and Biofilms.
    AlMatar M; Makky EA; Var I; Koksal F
    Curr Drug Deliv; 2018; 15(4):470-484. PubMed ID: 29219055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.